Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Molecumetics and Teijin begin oral thrombin inhibitor collaboration

Sep. 15, 1997

Pharmacological characterization of BIBU-52

Sep. 15, 1997

LG Chemical licenses thrombin inhibitor to Warner-Lambert

Sep. 15, 1997

Synthetic retinoids with anticoagulant effects

Sep. 15, 1997

L-374087: a new thrombin inhibitor developed at Merck & Co.

Sep. 12, 1997

Heparinase gene covered by U.S., European patents

Sep. 12, 1997

YM-60828: an orally active factor Xa inhibitor from Yamanouchi

Sep. 11, 1997

Reteplase and alteplase exhibit different profiles of fibrin binding at high doses

Sep. 10, 1997

U.S. patent for antithrombotic agents issued to Burnham Institute

Sep. 10, 1997

LG Chemical characterizes new thrombin inhibitor

Sep. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...